Skip to content
Home
John Jay Treanor, M.D.

John Jay Treanor, M.D.

About Me

Dr. Treanor is a graduate of the University of Rochester Medical School and a residency in Internal Medicine at the University of Vermont. He returned to the University of Rochester for Fellowship in Infectious Diseases and also trained at the Laboratory of Infectious Diseases, NIH. Dr. Treanor pr...
Dr. Treanor is a graduate of the University of Rochester Medical School and a residency in Internal Medicine at the University of Vermont. He returned to the University of Rochester for Fellowship in Infectious Diseases and also trained at the Laboratory of Infectious Diseases, NIH. Dr. Treanor primarily sees inpatients with general ID problems at UR Medicine and has a small outpatient clinic.

Faculty Appointments

Professor (Part-Time) - Department of Medicine, Infectious Diseases (SMD)

Credentials

Post-doctoral Training & Residency

1987-1989 Senior Staff Fellow
Laboratory of Infectious Disease
National Institutes of Health
Bethesda, Md.

1985-1987 Senior Instructor
Infectious Disease Unit
University of Rochester
Rochester, N.Y.

1982-1985 Fellow in Infectious Diseases
University of Rochester
Rochester, N.Y.

1980-1982 Medical Resident
University of Vermont
Burlington, Vermont

1979-1980 Medical Intern
University of Vermont
Burlington, Vermont

Education

MD | Univ Rochester Sch Med/Dent. Medicine. 1979

BA | Canisius College. Biology. 1975

Research

My research interests are primarily focused on control of influenza with vaccines and antivirals, and on the safety and immunogenicity of vaccines for emerging infectious diseases. Our group currently conducts clinical studies evaluating candidate live attenuated influenza vaccines for prevention o...
My research interests are primarily focused on control of influenza with vaccines and antivirals, and on the safety and immunogenicity of vaccines for emerging infectious diseases. Our group currently conducts clinical studies evaluating candidate live attenuated influenza vaccines for prevention of pandemic influenza, and studies to document and evaluate the priming effects of pandemic vaccines on subsequent booster vaccines. As director of the New York Influenza Center of Excellence, I collaborate with colleagues in microbiology and immunology to perform detailed evaluations of the human humoral and cellular immune responses to influenza infection and vaccination. Our group is also active in clinical trials to evaluate new vaccines for Norovirus and other viral pathogens in the field and in the human experimental infection model.

Patents

Modified Phage for Displaying Post-Translationally Modified Proteins and Uses Thereof

Issue date: June 17, 2014

Patent #: 8,754,015

Country: United States

Inventors: Stephen Dewhurst, John J Treanor

Attenuated Influenza Vaccines and Uses Thereof

Issue date: September 07, 2021

Patent #: 2,918,739

Country: Canada

Inventors: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Attenuated Influenza Vaccines and Uses Thereof

Issue date: April 28, 2020

Patent #: ZL201480045309.0

Country: China, People's Republic of

Inventors: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Attenuated Influenza Vaccines and Uses Thereof

Issue date: June 19, 2019

Patent #: 3022298

Country: Europe

Inventors: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Attenuated Influenza Vaccines and Uses Thereof

Issue date: January 30, 2018

Patent #: 9,878,032

Country: United States

Inventors: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Attenuated Influenza Vaccines and Uses Thereof

Issue date: June 18, 2019

Patent #: 10,323,231

Country: United States

Inventors: Andrew Cox, Stephen Dewhurst, John J Treanor

Attenuated Influenza Vaccines and Uses Thereof

Issue date: June 19, 2019

Patent #: FR3022298

Country: France

Inventors: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Attenuated Influenza Vaccines and Uses Thereof

Issue date: June 19, 2019

Patent #: 602014048

Country: Germany

Inventors: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Attenuated Influenza Vaccines and Uses Thereof

Issue date: June 19, 2019

Patent #: GB3022298

Country: United Kingdom

Inventors: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Publications

Journal Articles

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody.

Nogales A, Piepenbrink MS, Wang J, Ortega S, Basu M, Fucile CF, Treanor JJ, Rosenberg AF, Zand MS, Keefer MC, Martinez-Sobrido L, Kobie JJ

Scientific reports.. 2018 March 128 (1):4374. Epub 03/12/2018.

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE

Proceedings of the National Academy of Sciences of the United States of America.. 2017 November 21114 (47):12578-12583. Epub 11/06/2017.

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.

Ramani S, Neill FH, Ferreira J, Treanor JJ, Frey SE, Topham DJ, Goodwin RR, Borkowski A, Baehner F, Mendelman PM, Estes MK, Atmar RL

Clinical and vaccine immunology : CVI.. 2017 May 24 (5)Epub 05/05/2017.

Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.

Treanor JJ, Chu L, Essink B, Muse D, El Sahly HM, Izikson R, Goldenthal KL, Patriarca P, Dunkle LM

Vaccine.. 2017 February 735 (6):923-928. Epub 01/11/2017.

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.

Stadlbauer D, Rajabhathor A, Amanat F, Kaplan D, Masud A, Treanor JJ, Izikson R, Cox MM, Nachbagauer R, Krammer F

mSphere.. 2017 2 (6)Epub 12/13/2017.

CLINICAL PRACTICE. Influenza Vaccination.

Treanor JJ

The New England journal of medicine.. 2016 September 29375 (13):1261-8. Epub 1900 01 01.

Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.

Tapia MD, Sow SO, Tamboura B, Tégueté I, Pasetti MF, Kodio M, Onwuchekwa U, Tennant SM, Blackwelder WC, Coulibaly F, Traoré A, Keita AM, Haidara FC, Diallo F, Doumbia M, Sanogo D, DeMatt E, Schluterman NH, Buchwald A, Kotloff KL, Chen WH, Orenstein EW, Orenstein LA, Villanueva J, Bresee J, Treanor J, Levine MM

The Lancet. Infectious diseases.. 2016 September 16 (9):1026-1035. Epub 05/31/2016.

Incidence and viral aetiologies of acute respiratory illnesses (ARIs) in the United States: a population-based study.

Szilagyi PG, Blumkin A, Treanor JJ, Gallivan S, Albertin C, Lofthus GK, Schnabel KC, Donahue JG, Thompson MG, Shay DK

Epidemiology and infection.. 2016 July 144 (10):2077-86. Epub 03/02/2016.

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.

Henry Dunand CJ, Leon PE, Huang M, Choi A, Chromikova V, Ho IY, Tan GS, Cruz J, Hirsh A, Zheng NY, Mullarkey CE, Ennis FA, Terajima M, Treanor JJ, Topham DJ, Subbarao K, Palese P, Krammer F, Wilson PC

Cell host & microbe.. 2016 June 819 (6):800-13. Epub 1900 01 01.

Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.

DeDiego ML, Anderson CS, Yang H, Holden-Wiltse J, Fitzgerald T, Treanor JJ, Topham DJ

Immunology.. 2016 June 148 (2):160-73. Epub 03/30/2016.

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine.

Wright PF, Hoen AG, Ilyushina NA, Brown EP, Ackerman ME, Wieland-Alter W, Connor RI, Jegaskanda S, Rosenberg-Hasson Y, Haynes BC, Luke CJ, Subbarao K, Treanor JJ

Open forum infectious diseases.. 2016 April 3 (2):ofw108. Epub 05/23/2016.

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9).

Sobhanie M, Matsuoka Y, Jegaskanda S, Fitzgerald T, Mallory R, Chen Z, Luke C, Treanor J, Subbarao K

The Journal of infectious diseases.. 2016 March 15213 (6):922-9. Epub 12/09/2015.

Editorial Commentary: Is Prepandemic Vaccination a Wise Investment?

Treanor J

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2016 February 1562 (4):499-500. Epub 11/18/2015.

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.

Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, Nowalk MP, Talbot HK, Treanor JJ, Belongia EA, Murthy K, Jackson LA, Petrie JG, Zimmerman RK, Griffin MR, McLean HQ, Fry AM

Pediatrics.. 2016 February 137 (2):e20153279. Epub 01/05/2016.

Prospects for Broadly Protective Influenza Vaccines.

Treanor JJ

American journal of preventive medicine.. 2015 December 49 (6 Suppl 4):S355-63. Epub 1900 01 01.

Prospects for broadly protective influenza vaccines.

Treanor JJ

Vaccine.. 2015 November 2733 Suppl 4 :D39-45. Epub 09/01/2015.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine.

Bryant KA, Frenck R, Gurtman A, Rubino J, Treanor J, Thompson A, Jones TR, Sundaraiyer V, Baxter LM, Gruber WC, Emini EA, Scott DA, Schmoele-Thoma B

Vaccine.. 2015 October 2633 (43):5854-5860. Epub 09/09/2015.

High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine.

Halliley JL, Khurana S, Krammer F, Fitzgerald T, Coyle EM, Chung KY, Baker SF, Yang H, Martínez-Sobrido L, Treanor JJ, Subbarao K, Golding H, Topham DJ, Sangster MY

The Journal of infectious diseases.. 2015 October 15212 (8):1270-8. Epub 04/02/2015.

Abundance and specificity of influenza reactive circulating memory follicular helper and non-follicular helper CD4 T cells in healthy adults.

Leddon SA, Richards KA, Treanor JJ, Sant AJ

Immunology.. 2015 September 146 (1):157-62. Epub 07/14/2015.

Serological Correlates of Protection against a GII.4 Norovirus.

Atmar RL, Bernstein DI, Lyon GM, Treanor JJ, Al-Ibrahim MS, Graham DY, Vinjé J, Jiang X, Gregoricus N, Frenck RW, Moe CL, Chen WH, Ferreira J, Barrett J, Opekun AR, Estes MK, Borkowski A, Baehner F, Goodwin R, Edmonds A, Mendelman PM

Clinical and vaccine immunology : CVI.. 2015 August 22 (8):923-9. Epub 06/03/2015.

Seasonal Influenza Can Poise Hosts for CD4 T-Cell Immunity to H7N9 Avian Influenza.

Richards KA, Nayak J, Chaves FA, DiPiazza A, Knowlden ZA, Alam S, Treanor JJ, Sant AJ

The Journal of infectious diseases.. 2015 July 1212 (1):86-94. Epub 12/09/2014.

A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.

Baz M, Paskel M, Matsuoka Y, Zengel JR, Cheng X, Treanor JJ, Jin H, Subbarao K

Journal of virology.. 2015 July 89 (13):6907-17. Epub 04/22/2015.

Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.

Nayak JL, Richards KA, Yang H, Treanor JJ, Sant AJ

The Journal of infectious diseases.. 2015 May 1211 (9):1408-17. Epub 11/06/2014.

Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.

Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinjé J, Gregoricus N, Frenck RW, Moe CL, Al-Ibrahim MS, Barrett J, Ferreira J, Estes MK, Graham DY, Goodwin R, Borkowski A, Clemens R, Mendelman PM

The Journal of infectious diseases.. 2015 March 15211 (6):870-8. Epub 09/09/2014.

Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans.

Watson JM, Francis JN, Mesens S, Faiman GA, Makin J, Patriarca P, Treanor JJ, Georges B, Bunce CJ

Virology journal.. 2015 February 312 :13. Epub 02/03/2015.

Live attenuated and inactivated influenza vaccines in children.

Ilyushina NA, Haynes BC, Hoen AG, Khalenkov AM, Housman ML, Brown EP, Ackerman ME, Treanor JJ, Luke CJ, Subbarao K, Wright PF

The Journal of infectious diseases.. 2015 February 1211 (3):352-60. Epub 08/26/2014.

A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.

Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Treanor JJ, Jin H, Subbarao K

Journal of virology.. 2015 February 89 (3):1652-9. Epub 11/19/2014.

Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine.

Sundararajan A, Sangster MY, Frey S, Atmar RL, Chen WH, Ferreira J, Bargatze R, Mendelman PM, Treanor JJ, Topham DJ

Vaccine.. 2015 January 1533 (4):568-76. Epub 11/22/2014.

Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel.

Laguio-Vila MR, Thompson MG, Reynolds S, Spencer SM, Gaglani M, Naleway A, Ball S, Bozeman S, Baker S, Martínez-Sobrido L, Levine M, Katz J, Fry AM, Treanor JJ

Open forum infectious diseases.. 2015 January 2 (1):ofu115. Epub 01/03/2015.

A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.

Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, Goodwin R, Borkowski A, Clemens R, Mendelman PM

The Journal of infectious diseases.. 2014 December 1210 (11):1763-71. Epub 06/20/2014.

Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.

Babu TM, Levine M, Fitzgerald T, Luke C, Sangster MY, Jin H, Topham D, Katz J, Treanor J, Subbarao K

Vaccine.. 2014 November 2832 (50):6798-804. Epub 10/16/2014.

Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines?

Donahue JG, Kieke BA, Szilagy PG, Blumkin AK, Hilgemann D, Dana Flanders W, Shay DK, Meece J, Gallivan S, Treanor J, Belongia EA

Vaccine.. 2014 November 1232 (48):6440-4. Epub 10/03/2014.

Expanding the options for confronting pandemic influenza.

Treanor JJ

JAMA.. 2014 October 8312 (14):1401-2. Epub 1900 01 01.

Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, Martin E, Gurunathan S, Nathan R, Greenberg DP, Tornieporth NG, Decker MD, Talbot HK

The New England journal of medicine.. 2014 August 14371 (7):635-45. Epub 1900 01 01.

Use of bacteriophage particles displaying influenza virus hemagglutinin for the detection of hemagglutination-inhibition antibodies.

Domm W, Brewer M, Baker SF, Feng C, Martínez-Sobrido L, Treanor J, Dewhurst S

Journal of virological methods.. 2014 March 197 :47-50. Epub 12/06/2013.

Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody.

Kobie JJ, Treanor JJ, Ritchlin CT

Immunological investigations.. 2014 43 (6):606-15. Epub 1900 01 01.

Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.

Treanor JJ, Essink B, Hull S, Reed S, Izikson R, Patriarca P, Goldenthal KL, Kohberger R, Dunkle LM

Vaccine.. 2013 November 1931 (48):5760-5. Epub 09/27/2013.

B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination.

Sangster MY, Baer J, Santiago FW, Fitzgerald T, Ilyushina NA, Sundararajan A, Henn AD, Krammer F, Yang H, Luke CJ, Zand MS, Wright PF, Treanor JJ, Topham DJ, Subbarao K

Clinical and vaccine immunology : CVI.. 2013 June 20 (6):867-76. Epub 04/10/2013.

Editorial commentary: influenza vaccine: glass half full or half empty?

Treanor JJ, Szilagyi P

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2013 May 56 (10):1370-2. Epub 02/14/2013.

New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.

Poland GA, Fleming DM, Treanor JJ, Maraskovsky E, Luke TC, Ball EM, Poland CM

Vaccine.. 2013 April 1731 Suppl 1 :A1-20. Epub 1900 01 01.

CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.

Nayak JL, Fitzgerald TF, Richards KA, Yang H, Treanor JJ, Sant AJ

The Journal of infectious diseases.. 2013 January 15207 (2):297-305. Epub 11/12/2012.

Increase in IFN?(-)IL-2(+) cells in recent human CD4 T cell responses to 2009 pandemic H1N1 influenza.

Weaver JM, Yang H, Roumanes D, Lee FE, Wu H, Treanor JJ, Mosmann TR

PloS one.. 2013 8 (3):e57275. Epub 03/20/2013.

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.

Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, Shay DK,

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2012 October 55 (7):951-9. Epub 07/25/2012.

Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.

Santiago FW, Emo KL, Fitzgerald T, Treanor JJ, Topham DJ

Vaccine.. 2012 June 2930 (31):4606-16. Epub 05/15/2012.

Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.

Santiago FW, Fitzgerald T, Treanor JJ, Topham DJ

Vaccine.. 2011 November 829 (48):8888-97. Epub 09/28/2011.

Antibody response to inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with and without HIV.

Tiu CT, Lin YS, Pagala M, Ghitan M, Treanor JJ, Fitzgerald T, Xiao YY, Ushumirskiy S, Wong SS, Javier EM, Xu Y, Minkoff HL, Chapnick EK

Journal of acquired immune deficiency syndromes : JAIDS.. 2011 November 158 (3):e99-102. Epub 1900 01 01.

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.

Treanor JJ, Sahly HE, King J, Graham I, Izikson R, Kohberger R, Patriarca P, Cox M

Vaccine.. 2011 October 1329 (44):7733-9. Epub 08/09/2011.

CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses.

Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, Treanor JJ, Topham DJ

Vaccine.. 2011 March 329 (11):2159-68. Epub 01/04/2011.

Label-free, arrayed sensing of immune response to influenza antigens.

Mace CR, Topham DJ, Mosmann TR, Quataert SA, Treanor JJ, Miller BL

Talanta.. 2011 January 1583 (3):1000-5. Epub 11/10/2010.

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.

Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, Anandarajah AP, Looney RJ, Thiele RG, Anolik JH, Coca A, Wei C, Rosenberg AF, Feng C, Treanor JJ, Lee FE, Sanz I

Arthritis research & therapy.. 2011 13 (6):R209. Epub 12/16/2011.

Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults.

Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, Liu G, Kavita U, Song L, Dark I, Shaw A

Vaccine.. 2010 December 628 (52):8268-74. Epub 10/20/2010.

Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.

El-Kamary SS, Pasetti MF, Mendelman PM, Frey SE, Bernstein DI, Treanor JJ, Ferreira J, Chen WH, Sublett R, Richardson C, Bargatze RF, Sztein MB, Tacket CO

The Journal of infectious diseases.. 2010 December 1202 (11):1649-58. Epub 10/27/2010.

Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization.

Halliley JL, Kyu S, Kobie JJ, Walsh EE, Falsey AR, Randall TD, Treanor J, Feng C, Sanz I, Lee FE

Vaccine.. 2010 April 3028 (20):3582-7. Epub 03/16/2010.

Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection.

Bernard MP, Bancos S, Chapman TJ, Ryan EP, Treanor JJ, Rose RC, Topham DJ, Phipps RP

Vaccine.. 2010 February 328 (5):1363-72. Epub 11/24/2009.

B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant.

Baer J, Santiago F, Yang H, Wu H, Jeanne-Holden-Wiltse , Treanor J, Topham DJ

Vaccine.. 2010 January 2228 (4):907-15. Epub 11/21/2009.

Antiviral treatment and prophylaxis of influenza virus in children.

Nayak JL, Treanor JJ

Pediatric annals.. 2009 December 38 (12):667-74. Epub 1900 01 01.

Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines.

Pichichero ME, Gentile A, Giglio N, Alonso MM, Fernandez Mentaberri MV, Zareba G, Clarkson T, Gotelli C, Gotelli M, Yan L, Treanor J

The Journal of pediatrics.. 2009 October 155 (4):495-9. Epub 06/26/2009.

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.

Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ

The Journal of infectious diseases.. 2009 July 15200 (2):172-80. Epub 1900 01 01.

Simulation and prediction of the adaptive immune response to influenza A virus infection.

Lee HY, Topham DJ, Park SY, Hollenbaugh J, Treanor J, Mosmann TR, Jin X, Ward B, Miao H, Holden-Wiltse J, Perelson AS, Zand M, Wu H

Journal of virology.. 2009 July 83 (14):7151-65. Epub 05/13/2009.

Recombinant proteins produced in insect cells.

Treanor J

Current topics in microbiology and immunology.. 2009 333 :211-25. Epub 1900 01 01.

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ

The Journal of infectious diseases.. 2008 September 1198 (5):635-41. Epub 1900 01 01.

Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

Mullen GE, Ellis RD, Miura K, Malkin E, Nolan C, Hay M, Fay MP, Saul A, Zhu D, Rausch K, Moretz S, Zhou H, Long CA, Miller LH, Treanor J

PloS one.. 2008 August 133 (8):e2940. Epub 08/13/2008.

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.

Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, Graham I, Dekker CL, Ho D, Winokur P, Walter E, Bennet J, Formica N, Hartel G, Skeljo M, Edwards KM

Vaccine.. 2008 July 2926 (32):4057-61. Epub 06/02/2008.

Objective and subjective socioeconomic status and susceptibility to the common cold.

Cohen S, Alper CM, Doyle WJ, Adler N, Treanor JJ, Turner RB

Health psychology : official journal of the Division of Health Psychology, American Psychological Association.. 2008 March 27 (2):268-74. Epub 1900 01 01.

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans.

Zangwill KM, Treanor JJ, Campbell JD, Noah DL, Ryea J

The Journal of infectious diseases.. 2008 February 15197 (4):580-3. Epub 1900 01 01.

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.

Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J

Pediatrics.. 2008 February 121 (2):e208-14. Epub 1900 01 01.

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial.

Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM, Meyer AL, Holden-Wiltse J, Liang H, Gilbert A, Cox M

JAMA.. 2007 April 11297 (14):1577-82. Epub 1900 01 01.

Pandemic (avian) influenza.

Rajagopal S, Treanor J

Seminars in respiratory and critical care medicine.. 2007 April 28 (2):159-70. Epub 1900 01 01.

Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect.

Janicki-Deverts D, Cohen S, Doyle WJ, Turner RB, Treanor JJ

Brain, behavior, and immunity.. 2007 March 21 (3):301-7. Epub 10/18/2006.

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ

PLoS medicine.. 2007 February 4 (2):e59. Epub 1900 01 01.

Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.

Treanor J, Wu H, Liang H, Topham DJ

Vaccine.. 2006 November 1724 (47-48):6913-23. Epub 06/21/2006.

Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

Ward JI, Cherry JD, Chang SJ, Partridge S, Keitel W, Edwards K, Lee M, Treanor J, Greenberg DP, Barenkamp S, Bernstein DI, Edelman R,

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2006 July 1543 (2):151-7. Epub 06/05/2006.

Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.

Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay CM, Wolff M, She D, Cox MM

The Journal of infectious diseases.. 2006 May 1193 (9):1223-8. Epub 03/28/2006.

Kupffer cell-dependent hepatitis occurs during influenza infection.

Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, Crispe IN, Topham DJ, Pierce RH

The American journal of pathology.. 2006 April 168 (4):1169-78; quiz 1404-5. Epub 1900 01 01.

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M

The New England journal of medicine.. 2006 March 30354 (13):1343-51. Epub 1900 01 01.

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.

Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG

The Journal of infectious diseases.. 2006 March 15193 (6):760-4. Epub 02/13/2006.

The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.

Wright PF, Karron RA, Madhi SA, Treanor JJ, King JC, O'Shea A, Ikizler MR, Zhu Y, Collins PL, Cutland C, Randolph VB, Deatly AM, Hackell JG, Gruber WC, Murphy BR

The Journal of infectious diseases.. 2006 February 15193 (4):573-81. Epub 01/19/2006.

Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects.

Treanor J, Nolan C, O'Brien D, Burt D, Lowell G, Linden J, Fries L

Vaccine.. 2006 January 1624 (3):254-62. Epub 08/15/2005.

Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza a virus.

Cohen S, Alper CM, Doyle WJ, Treanor JJ, Turner RB

Psychosomatic medicine.. 2006 68 (6):809-15. Epub 11/13/2006.

Efficacy of an acellular pertussis vaccine among adolescents and adults.

Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, Greenberg DP, Keitel W, Barenkamp S, Bernstein DI, Edelman R, Edwards K,

The New England journal of medicine.. 2005 October 13353 (15):1555-63. Epub 1900 01 01.

Fever and progressive respiratory failure in three elderly family members.

Lee FE, Daigle CC, Urban MA, Metlay LA, Treanor JJ, Trawick DR

Chest.. 2005 September 128 (3):1863-4, 1865-7. Epub 1900 01 01.

Loneliness, social network size, and immune response to influenza vaccination in college freshmen.

Pressman SD, Cohen S, Miller GE, Barkin A, Rabin BS, Treanor JJ

Health psychology : official journal of the Division of Health Psychology, American Psychological Association.. 2005 May 24 (3):297-306. Epub 1900 01 01.

Cellular and humoral immunity following Snow Mountain virus challenge.

Lindesmith L, Moe C, Lependu J, Frelinger JA, Treanor J, Baric RS

Journal of virology.. 2005 March 79 (5):2900-9. Epub 1900 01 01.

Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.

Barroso L, Treanor J, Gubareva L, Hayden FG

Antiviral therapy.. 2005 10 (8):901-10. Epub 1900 01 01.

Rapid licensure of a new, inactivated influenza vaccine in the United States.

Treanor JJ, Campbell JD, Brady RC, Keitel WA, Drame M, Jain VK, Innis BL

Human vaccines. 2005 1 (6):239-44. Epub 11/05/2005.

Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults.

Halperin SA, Smith B, Clarke K, Treanor J, Mabrouk T, Germain M

Human vaccines. 2005 1 (1):37-42. Epub 01/12/2005.

Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.

Cherry JD, Chang SJ, Klein D, Lee M, Barenkamp S, Bernstein D, Edelman R, Decker MD, Greenberg DP, Keitel W, Treanor J, Ward JI

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2004 December 139 (11):1715-8. Epub 11/10/2004.

Serum antibody responses after intradermal vaccination against influenza.

Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G

The New England journal of medicine.. 2004 November 25351 (22):2286-94. Epub 11/03/2004.

Weathering the influenza vaccine crisis.

Treanor J

The New England journal of medicine.. 2004 November 11351 (20):2037-40. Epub 10/18/2004.

Experimental infection of humans with A2 respiratory syncytial virus.

Lee FE, Walsh EE, Falsey AR, Betts RF, Treanor JJ

Antiviral research.. 2004 September 63 (3):191-6. Epub 1900 01 01.

Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.

Le T, Cherry JD, Chang SJ, Knoll MD, Lee ML, Barenkamp S, Bernstein D, Edelman R, Edwards KM, Greenberg D, Keitel W, Treanor J, Ward JI,

The Journal of infectious diseases.. 2004 August 1190 (3):535-44. Epub 07/07/2004.

Dose-dependent neutralizing-antibody responses to vaccinia.

Belshe RB, Newman FK, Frey SE, Couch RB, Treanor JJ, Tacket CO, Yan L

The Journal of infectious diseases.. 2004 February 1189 (3):493-7. Epub 01/23/2004.

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.

Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P

The Journal of pediatrics.. 2004 February 144 (2):184-90. Epub 1900 01 01.

Influenza vaccine--outmaneuvering antigenic shift and drift.

Treanor J

The New England journal of medicine.. 2004 January 15350 (3):218-20. Epub 1900 01 01.

Psychological stress and antibody response to influenza vaccination: when is the critical period for stress, and how does it get inside the body?

Miller GE, Cohen S, Pressman S, Barkin A, Rabin BS, Treanor JJ

Psychosomatic medicine.. 2004 66 (2):215-23. Epub 1900 01 01.

Psychosocial factors and the response to influenza vaccination in older adults.

Moynihan JA, Larson MR, Treanor J, Duberstein PR, Power A, Shore B, Ader R

Psychosomatic medicine.. 2004 66 (6):950-3. Epub 1900 01 01.

Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding.

Falsey AR, Formica MA, Treanor JJ, Walsh EE

Journal of clinical microbiology.. 2003 September 41 (9):4160-5. Epub 1900 01 01.

Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.

Ison MG, Gnann JW, Nagy-Agren S, Treannor J, Paya C, Steigbigel R, Elliott M, Weiss HL, Hayden FG,

Antiviral therapy.. 2003 June 8 (3):183-90. Epub 1900 01 01.

Non-interference between two protein carriers when used with the same polysaccharide for pneumococcal conjugate vaccines in 2-year-old children.

Anderson P, Treanor J, Porcelli S, Pichichero M

Vaccine.. 2003 March 2821 (13-14):1554-9. Epub 1900 01 01.

Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.

Bernstein DI, Yan L, Treanor J, Mendelman PM, Belshe R,

The Pediatric infectious disease journal.. 2003 January 22 (1):28-34. Epub 1900 01 01.

Immune correlates of protection against influenza in the human challenge model.

Treanor J, Wright PF

Developments in biologicals.. 2003 115 :97-104. Epub 1900 01 01.

Clinical benefits with oseltamivir in treating influenza in adult populations : results of a pooled and subgroup analysis.

Singh S, Barghoorn J, Bagdonas A, Adler J, Treanor J, Kinnersley N, Ward P

Clinical drug investigation.. 2003 23 (9):561-9. Epub 1900 01 01.

Chronic stress in nonelderly caregivers: psychological, endocrine and immune implications.

Vedhara K, McDermott MP, Evans TG, Treanor JJ, Plummer S, Tallon D, Cruttenden KA, Schifitto G

Journal of psychosomatic research.. 2002 December 53 (6):1153-61. Epub 1900 01 01.

Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study.

Pichichero ME, Cernichiari E, Lopreiato J, Treanor J

Lancet.. 2002 November 30360 (9347):1737-41. Epub 1900 01 01.

Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.

Piedra PA, Yan L, Kotloff K, Zangwill K, Bernstein DI, King J, Treanor J, Munoz F, Wolff M, Cho I, Mendelman PM, Cordova J, Belshe RB

Pediatrics.. 2002 October 110 (4):662-72. Epub 1900 01 01.

Clinical responses to undiluted and diluted smallpox vaccine.

Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, Atmar RL, Edelman R, Nolan CM, Belshe RB,

The New England journal of medicine.. 2002 April 25346 (17):1265-74. Epub 03/28/2002.

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults.

Treanor J, Keitel W, Belshe R, Campbell J, Schiff G, Zangwill K, Wolff M, Klimov A, Levandowski R, Lambert L

Vaccine.. 2002 January 1520 (7-8):1099-105. Epub 1900 01 01.

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

Treanor JJ, Wilkinson BE, Masseoud F, Hu-Primmer J, Battaglia R, O'Brien D, Wolff M, Rabinovich G, Blackwelder W, Katz JM

Vaccine.. 2001 February 819 (13-14):1732-7. Epub 1900 01 01.

Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults.

Shelly MA, Pichichero ME, Treanor JJ

Scandinavian journal of infectious diseases.. 2001 33 (7):542-4. Epub 1900 01 01.

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.

Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, Wolff M

The Journal of infectious diseases.. 2000 March 181 (3):1133-7. Epub 1900 01 01.

Clinical and laboratory diagnosis of influenza virus infections.

Newton DW, Treanor JJ, Menegus MA

The American journal of managed care.. 2000 March 6 (5 Suppl):S265-75. Epub 1900 01 01.

Approaches to improved influenza vaccination.

Betts RF, Treanor JJ

Vaccine.. 2000 February 2518 (16):1690-5. Epub 1900 01 01.

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG

JAMA.. 2000 February 23283 (8):1016-24. Epub 1900 01 01.

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M

The Journal of pediatrics.. 2000 February 136 (2):168-75. Epub 1900 01 01.

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.

King JC, Treanor J, Fast PE, Wolff M, Yan L, Iacuzio D, Readmond B, O'Brien D, Mallon K, Highsmith WE, Lambert JS, Belshe RB

The Journal of infectious diseases.. 2000 February 181 (2):725-8. Epub 1900 01 01.

Respiratory viral infections in the elderly.

Treanor J, Falsey A

Antiviral research.. 1999 December 1544 (2):79-102. Epub 1900 01 01.

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.

Treanor JJ, Kotloff K, Betts RF, Belshe R, Newman F, Iacuzio D, Wittes J, Bryant M

Vaccine.. 1999 December 1018 (9-10):899-906. Epub 1900 01 01.

Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults.

Hasan MS, Agosti JM, Reynolds KK, Tanzman E, Treanor JJ, Evans TG

The Journal of infectious diseases.. 1999 December 180 (6):2023-6. Epub 1900 01 01.

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE

JAMA.. 1999 October 6282 (13):1240-6. Epub 1900 01 01.

Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial.

Tasker SA, Treanor JJ, Paxton WB, Wallace MR

Annals of internal medicine.. 1999 September 21131 (6):430-3. Epub 1900 01 01.

Production of influenza-stimulated tumor necrosis factor-alpha by monocytes following acute influenza infection in humans.

Kallas EG, Reynolds K, Andrews J, Treanor JJ, Evans TG

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.. 1999 July 19 (7):751-5. Epub 1900 01 01.

Detection of intracellular antigen-specific cytokines in human T cell populations.

Kallas EG, Gibbons DC, Soucier H, Fitzgerald T, Treanor JJ, Evans TG

The Journal of infectious diseases.. 1999 May 179 (5):1124-31. Epub 1900 01 01.

Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects.

Treanor JJ, Betts RF

Vaccine.. 1998 November 16 (18):1756-60. Epub 1900 01 01.

Characterization of pneumococcal specific antibodies in healthy unvaccinated adults.

Coughlin RT, White AC, Anderson CA, Carlone GM, Klein DL, Treanor J

Vaccine.. 1998 November 16 (18):1761-7. Epub 1900 01 01.

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M

The New England journal of medicine.. 1998 May 14338 (20):1405-12. Epub 1900 01 01.

Serum antibody responses of weanling mice and two-year-old children to pneumococcal-type 6A-protein conjugate vaccines of differing saccharide chain lengths.

Pichichero ME, Porcelli S, Treanor J, Anderson P

Vaccine.. 1998 January 16 (1):83-91. Epub 1900 01 01.

Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial.

Tasker SA, O'Brien WA, Treanor JJ, Weiss PJ, Olson PE, Kaplan AH, Wallace MR

Vaccine.. 1998 16 (9-10):1039-42. Epub 1900 01 01.

Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza.

Walker JB, Hussey EK, Treanor JJ, Montalvo A, Hayden FG

The Journal of infectious diseases.. 1997 December 176 (6):1417-22. Epub 1900 01 01.

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K

The New England journal of medicine.. 1997 September 25337 (13):874-80. Epub 1900 01 01.

Expression and self-assembly of recombinant capsid protein from the antigenically distinct Hawaii human calicivirus.

Green KY, Kapikian AZ, Valdesuso J, Sosnovtsev S, Treanor JJ, Lew JF

Journal of clinical microbiology.. 1997 July 35 (7):1909-14. Epub 1900 01 01.

Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.

Shelly MA, Jacoby H, Riley GJ, Graves BT, Pichichero M, Treanor JJ

Infection and immunity.. 1997 January 65 (1):242-7. Epub 1900 01 01.

Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers.

Pichichero ME, Shelly MA, Treanor JJ

The Pediatric infectious disease journal.. 1997 January 16 (1):72-4. Epub 1900 01 01.

Economic impact of pertussis.

Pichichero ME, Treanor J

Archives of pediatrics & adolescent medicine.. 1997 January 151 (1):35-40. Epub 1900 01 01.

Human calicivirus genogroup II capsid sequence diversity revealed by analyses of the prototype Snow Mountain agent.

Hardy ME, Kramer SF, Treanor JJ, Estes MK

Archives of virology.. 1997 142 (7):1469-79. Epub 1900 01 01.

Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults.

Lakey DL, Treanor JJ, Betts RF, Smith GE, Thompson J, Sannella E, Reed G, Wilkinson BE, Wright PF

The Journal of infectious diseases.. 1996 October 174 (4):838-41. Epub 1900 01 01.

Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group.

Gruber WC, Belshe RB, King JC, Treanor JJ, Piedra PA, Wright PF, Reed GW, Anderson E, Newman F

The Journal of infectious diseases.. 1996 June 173 (6):1313-9. Epub 1900 01 01.

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

Treanor JJ, Betts RF, Smith GE, Anderson EL, Hackett CS, Wilkinson BE, Belshe RB, Powers DC

The Journal of infectious diseases.. 1996 June 173 (6):1467-70. Epub 1900 01 01.

Options for the Control of Influenza III: Proceedings of the third international conference on options for the control of influenza, Cairns, Australia,Phenotypic characteristics of A/AA/6/60 viruses and reassortants

Herlocher, M.L.; Clavo, A.C.; Treanor, J.; Maassab, H.F.;.

1996; : 634-646.

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.

Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK

JAMA.. 1996 275 (4):295-9. Epub 1900 01 01.

Development of an ELISA to detect MX virus, a human calicivirus in the snow Mountain agent genogroup.

Jiang X, Cubitt D, Hu J, Dai X, Treanor J, Matson DO, Pickering LK

The Journal of general virology.. 1995 November 76 ( Pt 11) :2739-47. Epub 1900 01 01.

Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein.

Jiang X, Matson DO, Ruiz-Palacios GM, Hu J, Treanor J, Pickering LK

Journal of clinical microbiology.. 1995 June 33 (6):1452-5. Epub 1900 01 01.

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults.

Powers DC, Smith GE, Anderson EL, Kennedy DJ, Hackett CS, Wilkinson BE, Volvovitz F, Belshe RB, Treanor JJ

The Journal of infectious diseases.. 1995 June 171 (6):1595-9. Epub 1900 01 01.

Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants.

Treanor JJ, Clark HF, Pichichero M, Christy C, Gouvea V, Shrager D, Palazzo S, Offit P

The Pediatric infectious disease journal.. 1995 April 14 (4):301-7. Epub 1900 01 01.

Acute respiratory tract infection in daycare centers for older persons.

Falsey AR, McCann RM, Hall WJ, Tanner MA, Criddle MM, Formica MA, Irvine CS, Kolassa JE, Barker WH, Treanor JJ

Journal of the American Geriatrics Society.. 1995 January 43 (1):30-6. Epub 1900 01 01.

Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus.

Treanor J, Perkins M, Battaglia R, Murphy BR

Journal of virology.. 1994 December 68 (12):7684-8. Epub 1900 01 01.

Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans.

Hayden FG, Tunkel AR, Treanor JJ, Betts RF, Allerheiligen S, Harris J

Antimicrobial agents and chemotherapy.. 1994 May 38 (5):1178-81. Epub 1900 01 01.

Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans.

Youngner JS, Treanor JJ, Betts RF, Whitaker-Dowling P

Journal of clinical microbiology.. 1994 March 32 (3):750-4. Epub 1900 01 01.

Viral infections of the respiratory tract: prevention and treatment.

Treanor JJ

International journal of antimicrobial agents.. 1994 March 4 (1):1-22. Epub 1900 01 01.

Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults.

Treanor J, Dumyati G, O'Brien D, Riley MA, Riley G, Erb S, Betts R

The Journal of infectious diseases.. 1994 February 169 (2):402-7. Epub 1900 01 01.

Evaluation of a bovine-human rotavirus reassortant vaccine in infants.

Christy C, Offit P, Clark HF, Treanar J

The Journal of infectious diseases.. 1993 December 168 (6):1598-9. Epub 1900 01 01.

Cryptococcal peritonitis: report of a case developing during continuous ambulatory peritoneal dialysis and review of the literature.

Yinnon AM, Solages A, Treanor JJ

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 1993 October 17 (4):736-41. Epub 1900 01 01.

Evaluation of live attenuated cold-adapted influenza B/Yamagata/16/88 reassortant virus vaccine in healthy adults.

Treanor JJ, Betts RF

The Journal of infectious diseases.. 1993 August 168 (2):455-9. Epub 1900 01 01.

Subclass-specific serum antibody responses to recombinant Norwalk virus capsid antigen (rNV) in adults infected with Norwalk, Snow Mountain, or Hawaii virus.

Treanor JJ, Jiang X, Madore HP, Estes MK

Journal of clinical microbiology.. 1993 June 31 (6):1630-4. Epub 1900 01 01.

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.

Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF

Annals of internal medicine.. 1992 October 15117 (8):625-33. Epub 1900 01 01.

The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect.

Subbarao EK, Perkins M, Treanor JJ, Murphy BR

Virus research.. 1992 September 125 (1-2):37-50. Epub 1900 01 01.

Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings.

Falsey AR, Treanor JJ, Betts RF, Walsh EE

Journal of the American Geriatrics Society.. 1992 February 40 (2):115-9. Epub 1900 01 01.

Intragenic suppression of a deletion mutation of the nonstructural gene of an influenza A virus.

Treanor JJ, Buja R, Murphy BR

Journal of virology.. 1991 August 65 (8):4204-10. Epub 1900 01 01.

Characterization of the attenuating M and NP gene segments of the avian influenza A/Mallard/78 virus during in vitro production of avian-human reassortant vaccine viruses and after replication in humans and primates.

Treanor JJ, Tierney EL, London WT, Murphy BR

Vaccine.. 1991 July 9 (7):495-501. Epub 1900 01 01.

Antigenic relatedness among the Norwalk-like agents by serum antibody rises.

Madore HP, Treanor JJ, Buja R, Dolin R

Journal of medical virology.. 1990 October 32 (2):96-101. Epub 1900 01 01.

Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.

Treanor JJ, Roth FK, Betts RF

Journal of clinical microbiology.. 1990 March 28 (3):596-9. Epub 1900 01 01.

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice.

Treanor JJ, Tierney EL, Zebedee SL, Lamb RA, Murphy BR

Journal of virology.. 1990 March 64 (3):1375-7. Epub 1900 01 01.

Nucleotide sequence of the avian influenza A/Mallard/NY/6750/78 virus polymerase genes.

Treanor J, Kawaoka Y, Miller R, Webster RG, Murphy B

Virus research.. 1989 November 14 (3):257-69. Epub 1900 01 01.

The B allele of the NS gene of avian influenza viruses, but not the A allele, attenuates a human influenza A virus for squirrel monkeys.

Treanor JJ, Snyder MH, London WT, Murphy BR

Virology.. 1989 July 171 (1):1-9. Epub 1900 01 01.

Development of an enzyme immunoassay for the Hawaii agent of viral gastroenteritis.

Treanor JJ, Madore HP, Dolin R

Journal of virological methods.. 1988 December 22 (2-3):207-14. Epub 1900 01 01.

Production of a monoclonal antibody against the Snow Mountain agent of gastroenteritis by in vitro immunization of murine spleen cells.

Treanor J, Dolin R, Madore HP

Proceedings of the National Academy of Sciences of the United States of America.. 1988 May 85 (10):3613-7. Epub 1900 01 01.

Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans.

Treanor JJ, Betts RF, Erb SM, Roth FK, Dolin R

The Journal of infectious diseases.. 1987 August 156 (2):379-83. Epub 1900 01 01.

Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine.

Christy C, Madore HP, Treaner JJ, Pray K, Kapikian AZ, Chanock RM, Dolin R

The Journal of infectious diseases.. 1986 December 154 (6):1045-7. Epub 1900 01 01.

Enzyme-linked immunosorbent assays for Snow Mountain and Norwalk agents of viral gastroenteritis.

Madore HP, Treanor JJ, Pray KA, Dolin R

Journal of clinical microbiology.. 1986 September 24 (3):456-9. Epub 1900 01 01.

Radioimmunoassay for detection of the Snow Mountain Agent of viral gastroenteritis.

Dolin R, Roessner KD, Treanor JJ, Reichman RC, Phillips M, Madore HP

Journal of medical virology.. 1986 May 19 (1):11-8. Epub 1900 01 01.

Characterization of the Snow Mountain agent of viral gastroenteritis.

Madore HP, Treanor JJ, Dolin R

Journal of virology.. 1986 May 58 (2):487-92. Epub 1900 01 01.